BioNTech acquires GMP manufacturing site to establish new mRNA vaccine facility in Singapore
BioNTech’s Singapore facility will create regional manufacturing capacities that will support BioNTech’s growing pipeline of mRNA-based vaccines and therapeutics across...
Read moreDetails